Company: SMNR
Filing Date: 2025-07-23
Form Type: S-4/A
Source: 0001193125-25-163401
Chunk: 337

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-23
Form: S-4/A
Chunk 337
---
          | 75,332 |     |            | 238,816 |     |               |  2,853 |     |          | — |     |            | 235,963 |
| Eli Lilly and Company (NYSE:LLY)                   |     |          | 26,467 |     |            | 844,099 |     |               |  2,819 |     |          | — |     |            | 841,280 |
| Viatris Inc. (NasdaqGS:VTRS)                       |     |          | 18,371 |     |            |  32,180 |     |               |    992 |     |          | — |     |            |  31,188 |
| Teva Pharmaceutical Industries Limited (NYSE:TEVA) |     |          | 20,273 |     |            |  39,681 |     |               |  3,226 |     |          | — |     |            |  36,455 |
| Dr. Reddy’s Laboratories Limited (BSE:500124)      |     |          |    239 |     |            |  13,737 |     |               |     85 |     |          | — |     |            |  13,652 |
| Collegium Pharmaceutical, Inc. (NasdaqGS:COLL)     |     |          |    674 |     |            |   1,857 |     |               |    239 |     |          | — |     |            |   1,618 |
| AbbVie Inc. (NYSE:ABBV)                            |     |          | 60,579 |     |            | 398,357 |     |               | 12,814 |     |          | — |     |            | 385,543 |
| Axsome Therapeutics, Inc. (NasdaqGM:AXSM)          |     |          |    186 |     |            |   4,259 |     |               |    386 |     |          | — |     |            |   3,873 |

Notes:

| (1) | Values in thousands of US dollars, except per share data. |

| (2) | Source: S&P Capital IQ. |

189

Beta Calculation Information

| Comparable Company Names                           |     | Levered Beta 
 (5Y)         |      |     |